Allogene Therapeutics(ALLO.US)

Event Tracking

Apr13

Allogene Therapeutics Reports Mid-Term Data on Experimental Blood Cancer Therapy

11:33

Allogene Therapeutics Announces Positive Interim Results from cema-cel's Phase II Trial

11:31

Mar12

Allogene Therapeutics released FY2025 earnings on March 12 After-Market EST, actual revenue USD 0 (forecast USD 1.67 K), actual EPS USD -0.8652 (forecast USD -0.9289)

23:00

Allogene Therapeutics released FY2025 Q4 earnings on March 12 After-Market EST, actual revenue USD 0 (forecast USD 2 K), actual EPS USD -0.1717 (forecast USD -0.2171)

23:00

Mar5

Allogene Therapeutics to Release FY2025 Q4 Earnings on March 12 After-Market EST, Forecast Revenue USD 2K, EPS USD -0.2164

00:51

Nov7

Oppenheimer and William Blair Analysts Reiterate Buy Rating on Allogene Therapeutics

02:56